期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 127, 期 7, 页码 2473-2481出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI90595
关键词
-
资金
- NIH [P01 AI106697]
- Immune Tolerance Network [N01 AI15416]
- HONORS award from the American Society of Hematology
- NIH
Alloimmune T cells are central mediators of rejection and graft-versus-host disease in both solid organ and hematopoietic stem cell transplantation. Unique among immune responses in terms of its strength and diversity, the T cell alloresponse reflects extensive genetic polymorphisms between allogeneic donors and recipients, most prominently within the major histocompatibility complex (MHC), which encodes human leukocyte antigens (HLAs) in humans. The repertoire of alloreactive T cell clones is distinct for every donor-recipient pair and includes potentially thousands of unique HLA/peptide specificities. The extraordinary magnitude of the primary alloresponse and diversity of the T cell population mediating it have presented technical challenges to its study in humans. High-throughput T cell receptor sequencing approaches have opened up new possibilities for tackling many fundamental questions about this important immunologic phenomenon.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据